Termination of pregnancy with mifepristone and prostaglandin suppresses transiently circulating glucocorticoid bioactivity

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 323-326

  Heikinheimo, Oskari ^a,b   Raivio, Taneli ^b   Honkanen, Helena ^a   Ranta, Sirpa ^b   Jänne, Olli A ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; MIFEPRISTONE; MISOPROSTOL; PROSTAGLANDIN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; NORMAL HUMAN; PREGNANCY TERMINATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEROID BLOOD LEVEL;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADULT; BIOLOGICAL ASSAY; DRUG SYNERGISM; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MIFEPRISTONE; MISOPROSTOL; PREGNANCY;

EID: 0037244582     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020799     Document Type: Article

References (19)

1. Bartley J, Tong S, Everington D, Baird D 2000 Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 62:297-303
2. Bertagna X, Bertagna C, Luton J-P, Husson J-M, Girard F 1984 The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab 59:25-28
3. Gaillard R, Riondel A, Müller A, Herrmann W, Baulieu EE 1984 RU 486: A steroid with antiglucocorficosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci USA 81:3879-3882
4. Murphy A, Kettel LM, Morales A, Roberts V, Yen S 1993 Regression of uterine leiomyomata in response to the antiprogesterone RU486. J Clin Endocrinol Metab 76:513-517
5. Croxatto H, Salvatierra A, Croxatto H, Fuentealba B 1993 Effect of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum Reprod 8:201-207
6. Galliard R, Poffet D, Riondel A, Saurat J-H 1985 RU 486 inhibits peripheral effects of glucocorticoids in humans. J Clin Endocrinol Metab 61:1009-1011
7. Laue L, Lotze M, Chrousos G, Barnes K, Loriaux DL, Fleisher T 1990 Effect of chronic treatment with glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects. J Clin Endocrinol Metab 71:1474-1480
8. Spitz I, Bardin CW, Benton L, Robbins A 1998 Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338:1241-1247
9. World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation 2000 Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 107:524-530
10. Raivio T, Palvimo JJ, Kannisto S, Voutilainen R, Jänne OA 2002 Transactivation assay for determination of glucocorticoid bioactivity in human serum. J Clin Endocrinol Metab 87:3740-3744
11. Heikinheimo O, Tevilin M, Shoupe D, Croxatto H, Lähteenmäki P 1986 Quantitation of RU486 in human plasma by HPLC and RIA after column chromatography. Contraception 34:613-624
12. Demey-Ponsart E, Froidart JM, Sulon J, Sodoyez JC 1982 Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem 16:165-169
13. Heikinheimo O, Lähteenmäki P, Koivunen E, Shoupe D, Croxatto H, Luukkainen T, Lähteenmäki P 1987 Metabolism and serum binding of RU 486 in women after various single doses. Hum Reprod 2:379-385
14. Heikinheimo O, Kontula K, Croxatto H, Spitz I, Luukkainen T, Lähteenmäki P 1987 Plasma concentrations and receptor binding of RU 486 and its metabolites in humans. J Steroid Biochem 26:279-284
15. UK Multicenter Trial 1990 The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. Br J Obstet Gynaecol 97:480-486
16. Orth D, Kovacs W, DeBold R 1992 The adrenal cortex. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology, 8th Ed. Philadelphia: Saunders; 489-619
17. Nieman LK, Chrousos GP, Kellner C, Spitz IM, Nisula BC, Cutler GB, Merriam GR, Bardin CW, Loriaux DL 1985 Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 61:536-540
18. Beaufrere B, de Parscau L, Chatelain P, Morel Y, Aguercif M, Francois R 1987 RU 486 administration in a child with Cushing's syndrome [Letter]. Lancet 2:217
19. Newfield RS, Kalaitzoglou G, Licholai T, Chilton D, Ashraf J, Thompson EB, New MI 2000 Normocortisolemic Cushing's syndrome initially presenting with increased glucocorticoid receptor numbers. J Clin Endocrinol Metab 85:14-21